Physician profile
Ashley Slade
NPI 1700806072
$1,109.67
in general payments reported to CMS, 2019-2025
14 companies · $146 in 2025
The $146 reported for 2025 was more than what a typical Advanced Practice Midwife provider received nationally (typical 2025 total: $70.87).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $255 · 2022: $350 · 2023: $106 · 2024: $253 · 2025: $146.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $398 · Education: $107.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $398.13 |
| Education | $106.80 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Millicent US INC | $187.35 | 2023-2025 | Intrarosa, Femring, Femlyv |
| Abbvie INC. | $183.68 | 2021-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $135.66 | 2022-2025 | |
| Astellas Pharma US INC | $135.03 | 2022-2025 | Veozah |
| Aspira Women'S Health INC | $96.37 | 2021-2025 | Ova1 |
| Therapeuticsmd, INC. | $81.38 | 2021-2022 | |
| Pfizer INC. | $73.91 | 2021-2023 | |
| Evofem Biosciences, INC. | $62.64 | 2021-2022 | |
| Coopersurgical, INC. | $37.77 | 2022-2024 | Paragard T 380a |
| Mylan Pharmaceuticals INC. | $33.16 | 2022 | |
| Merck Sharp & Dohme LLC | $26.24 | 2024 | Gardasil 9, Gardasil |
| Hologic Sales and Service, LLC | $20.38 | 2022 | |
| Mayne Pharma Commercial LLC | $20.20 | 2022-2023 | |
| Urovant Sciences INC | $15.90 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ashley Slade listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.